C07C 217 - Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton

Patents for C07C 217 - Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton (13,958)
01/2005
01/05/2005	CN1183097C Benflumetol, intermediates thereof and their use against parasitical protozoa and trematodes
01/04/2005	US6838561 2-substituted-4-amino-phenol derivative compounds providing good oxidative coloration of hair and acceptable light fastness, fastness to shampooing and permanent wave treatment
01/04/2005	US6838470 Antiischemic agents; brain disorders; cardiovascular disorders
01/04/2005	CA2148827C Novel 3,3-diphenylpropylamines, their use and preparation
12/2004
12/30/2004	US20040267051 By reacting aldehydes or ketones with ammonia or primary/secondary amines in presence of hydrogen-donor and homogeneous transition metal/complex catalysts
12/30/2004	US20040267025 Compounds for the treatment of metabolic disorders
12/30/2004	US20040266867 2-(4-amino-3-chloro-5-trifluoromethyl-phenyl)-2-tert-butylaminoethanol hydrochloride; treating asthma and bronchitis
12/29/2004	WO2004112478A1 Surfactant compounds and agrochemical compositions
12/29/2004	WO2004058982A3 Asymmetric reductive amination of ketones
12/29/2004	EP1490325A1 Manufacture of phenyl ethylamine compounds, in particular venlafaxine
12/29/2004	EP1198450B1 Alkoxylated amines
12/29/2004	EP1171419B1 Biphenyl derivatives as antagonists of the neurokinine-1 receptor
12/29/2004	EP1073643B1 New heterocyclic compounds and their use in medicine, process for their preparation and pharmaceutical compositions containing them
12/29/2004	CN1182103C Novel ethylamine derivatives
12/29/2004	CN1181825C Use of colchinol derivatives in preparation of vascular damaging agents drug
12/28/2004	US6835853 Process for resolution of tamsulosin and compounds, compositions, and processes associated therewith
12/28/2004	US6835371 Diagnostic and therapeutic piperazine and piperidine compounds and process
12/23/2004	WO2004110979A2 Amino-propanol derivatives as sphingosine-1-phosphate receptor modulator
12/23/2004	WO2004110364A2 Thiotungstate analogues and uses thereof
12/23/2004	US20040260124 Tertiary amine and method for producing the same
12/23/2004	US20040260088 Novel compounds
12/23/2004	US20040255403 Primary intermediates for oxidative coloration of hair
12/23/2004	CA2527977A1 Amino-propanol derivatives as sphingosine-1-phosphate receptor modulator
12/23/2004	CA2527236A1 Thiotungstate analogues and uses thereof
12/22/2004	EP1487784A2 Novel trifluoromethylepinephrine compounds and methods of making and using thereof
12/22/2004	EP1487778A1 Substituted 4-aminocyclohexanols
12/22/2004	EP1487776A1 Acid and ester compounds and methods of using the same
12/22/2004	EP1487573A2 Catalysts and method for the production of amines
12/22/2004	EP1051147B1 Method for permanently deforming keratin fibers
12/21/2004	US6833479 Triethanolamine modified propylene oxide/ethylene oxide adducts
12/21/2004	CA2322989C Oxidation dyeing compositions containing a cationic coupling agent, novel cationic coupling agents
12/16/2004	WO2004108658A1 Method for the production of substituted 3-aryl-butyl amine compounds
12/16/2004	WO2004108645A1 Method for the treatment or prevention of lower urinary tract symptoms
12/16/2004	WO2003051936A8 Bidentate ligand based catalyst for the polymerization of olefins
12/16/2004	US20040254206 herbicides
12/16/2004	US20040253389 Fluorene compound and organic lumnescent device using the same
12/15/2004	EP1485344A1 Venlafaxine besylate
12/15/2004	EP1263711B1 Novel use of phenylheteroalkylamine derivatives
12/15/2004	EP1119543B1 N-aralkylaminotetralins as ligands for the neuropeptide y y5 receptor
12/15/2004	CN1554641A Process for preparing high purity low E type Tamoxifen citrate
12/15/2004	CN1179958C Cyclic substituted aminomethyl compounds and medicaments containing said compounds
12/15/2004	CN1179954C Substd. heterocyclic compounds, preparing process thereof and pharmaceutical composition contg. them
12/14/2004	US6831186 Antiinflammatory agents; autoimmune disease
12/09/2004	WO2004106280A1 CaSR ANTAGONIST
12/09/2004	WO2004105743A1 Deramciclane-fumarate tablets
12/09/2004	WO2004105697A2 Novel lipids for transfection of nucleic acids
12/09/2004	US20040249211 Process for the preparation of tolterodine
12/09/2004	US20040249185 Process for the arylation of aza-heterocycles with activated aromatics in presence of caesium carbonate
12/09/2004	US20040248989 Method for the treatment or prevention of lower urinary tract symptoms
12/09/2004	US20040248850 Compounds for the treatment of HIV infection
12/09/2004	CA2527431A1 Deramciclane-fumarate tablets
12/08/2004	EP1483236A1 Aminoalcohol derivatives as beta-3 adrenergic receptor agonists
12/08/2004	EP1483233A2 Substituted tetrahydroisoquinoline compounds, methods of making, and their use
12/08/2004	EP1483231A1 Novel cinnamate salts, method for production and use thereof as medicaments
12/08/2004	EP1483228A1 Nk1 antagonists
12/08/2004	CN1553985A Method of controlling asphaltene precipitation in a fluid
12/08/2004	CN1553890A Crystals of hydroxynorephedrine derivative
12/07/2004	US6828345 Tertiary amines such as 2-dimethylaminomethyl-1-(3-methoxy-phenyl)-6-methylcyclohexanol, used as analgesics
12/07/2004	US6828318 2-adamantylethylamines and their use in the treatment of conditions generally associated with abnormalities in glutamatergic transmission
12/07/2004	US6828271 To form transition metal complexes which are used in such as asymmetric hydrogenation of imines, asymmetric hydride transfer reactions, hydrosilylation, hydroboration, hydrovinylation hydroformylation, allylic alkylation, etc.
12/02/2004	WO2004058174A3 Indane acetic acid derivatives and their use as pharmaceutical agents, intermediates, and method of preparation
12/02/2004	WO2004026815A3 Phenol derivatives and their use as rotamase inhibitors
12/02/2004	US20040242871 Nitric oxide synthease inhibitors; antiinflamamtory agents; analgesics; inflamamtory bowel disorders; antiarthritic agents;
12/02/2004	US20040242692 4-(3-(2,6-Dimethoxybenzyloxy)phenyl)-4-oxobutyric acid or derivatives for treatment of insulin resistance syndrome, diabetes, cachexia, hyperlipidemia, fatty liver disease, obesity, atherosclerosis or arteriosclerosis
12/02/2004	US20040242686 Crystals of hydroxynorephedrine derivative
12/02/2004	US20040242654 Diaryl ether derivative, addition salt thereof, and immunosuppressant
12/02/2004	US20040237837 Benzophenone derivative linked to hydrophylic moiety; concurrently imparts wettability and long term storage stability
12/02/2004	DE10322408A1 Stickstoffhaltige monodentate Phosphine und deren Verwendung in der Katalyse Nitrogenous monodentate phosphines and their use in catalysis
12/02/2004	DE10321536A1 Aminoalkohol-basierte Tenside mit geringer Oberflächenspannung und deren Verwendung Aminoalcohol-based surfactants with low surface tension and their use
12/02/2004	DE10321421A1 Hydroaminomethylating terminal alkenes, to prepare amines useful e.g. as pharmaceuticals, by reacting with amine, hydrogen and carbon monoxide over catalyst containing rhodium and bidentate phosphorus ligand
12/01/2004	EP1481961A1 Process for producing (r)-3-hydroxy-3-(2-phenylethyl)hexanoic acid and its intermediate
12/01/2004	EP1480957A1 Hppars activators
12/01/2004	EP1359891A4 Primary intermediates for oxidative coloration of hair
12/01/2004	CN1550540A Biphenyl derivatives and organic electroluminescent device employing the same
12/01/2004	CN1177800C Method for the recemization of optically active amines
11/2004
11/30/2004	US6825382 Trifluoromethylepinephrine compounds and methods of making and using thereof
11/30/2004	US6825231 Substituted norbornylamino derivatives, processes for their preparation, their use as medicaments or diagnostics, and a medicament comprising them
11/25/2004	WO2004101581A2 Nitrogen-containing monodentate phosphines and their use in catalysis
11/25/2004	WO2004101492A1 Toremifene crystallization method
11/25/2004	WO2004007407A3 Fluorous tagging and scavenging reactants and methods of synthesis and use thereof
11/25/2004	US20040236148 Ferulic acid dimers and their pharmaceutically acceptable salts, their preparation and use thereof for treating dementia
11/25/2004	US20040236100 For therapy of insulin resistance syndrome, diabetes, hyperlipidemia, fatty liver disease, cachexia, obesity, atherosclerosis and arteriosclerosis
11/25/2004	US20040235961 Reacting optically active secondary amine with alkylation agent in presence of a base, thereby converting the secondary amine into an optically active tertiary amine and subjecting the tertiary amine to hydrogenolysis, producing the N-monoalkyl derivative; intermediates for drugs, agriculture
11/25/2004	US20040235905 preventing overload of Ca2+ ions in cells; ischemic heart diseases, ischemic cerebral diseases, ischemic renal diseases and in the protection of cells during thrombolytic therapy, angioplasty, bypass operation of coronary artery or organ transplantation and arrhythmias
11/25/2004	US20040235870 Protein kinase inhibitors
11/25/2004	CA2525890A1 Nitrogen-containing monodentate phosphines and their use in catalysis
11/24/2004	EP1478613A2 Substituted 10-aryl-11h-benzo[b]fluorenes and 7-aryl-5,6-dihydro-benz[a]anthracenes for selective effects on estrogen receptors
11/24/2004	EP1318976B1 Substituted aminopropoxyaryl derivatives useful as agonists for lxr
11/24/2004	EP1305306B1 2-adamantylethylamines and their use in the treatment of conditions generally associated with abnormalities in glutamatergic transmission
11/24/2004	EP1183231B1 Cytofectin dimers and methods of use thereof
11/24/2004	CN1549731A Stilbene derivatives and their use for binding and imaging amyloid plaques
11/24/2004	CN1176900C Process for hydrogenation of imines
11/23/2004	US6822119 Reacting 3,4-dihydro-6-methyl-4-phenyl-2h-benzopyran-2-one with dimethyl sulfate using phase transfer catalyst; desterification, reduction, amination, sulfonation, deprotecting, decyclization, and salt formation
11/23/2004	US6822118 Catalytic reaction using iridium compound under high pressure in presence of metal- or ammonium- chloride, bromide, or iodide and acid
11/23/2004	US6822094 Spiro compounds and their use
11/18/2004	US20040230072 Phosphodiesterase 4 inhibitors
11/18/2004	US20040229949 New 3-aryl propionic acid derivatives and analogs
11/18/2004	US20040229946 Antidiabetic agents
11/18/2004	US20040229910 Therapeutic compounds
11/18/2004	US20040229899 Compounds useful in the treatment of conditions mediated by peroxisome proliferator-activated receptors (PPAR)

1 ... 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60 61 62 63 64 65 ... 140